Delivery Order SPE2DB20D1100-SPE2DB24FD1M7
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RESTASIS 0.05% eye emulsion. The contract has a firm fixed price of $4,788.86 and a completion date of May 10, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
This is a $31,894.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of RESTASIS 0.05% eye emulsion. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. This delivery order is part of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,002.55 delivery order is for the supply of RESTASIS 0.05% eye emulsion 30s, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RESTASIS 0.05% eye emulsion. The award, with a ceiling value of $4,295.76, is a firm-fixed-price contract with an ultimate completion date of August 1, 2024. AmerisourceBergen, through its Corporate Office division, is responsible for providing these prescription eye medications to support the healthcare needs of military treatment...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $157,760.88 contract is for the delivery of RESTASIS 0.05% eye emulsion to support military treatment programs and facilities. Amerisourcebergen Drug Corp has an extensive history of providing pharmaceutical and medical supply products and services to DLA under various delivery orders. This award does...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply RESTASIS 0.05% eye emulsion to the U.S. government. The Delivery Order contract, valued at $4,363.48, was awarded on May 30, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of May 31, 2024. This contract is not set-aside and is awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the world's largest pharmaceutical distribution companies. The contract is for the supply of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,243.30 and a completion date of May 1, 2024. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the pharmaceutical product RESTASIS 0.05% Eye Emulsion, with a ceiling value of $1,447.54 and a period of performance through February 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RESTASIS 0.05% eye emulsion. The $3,576.43 order, which has a completion date of December 29, 2023, is part of Amerisourcebergen Drug Corp's indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as a prime...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order with a ceiling value of $7,363.71 under the Defense Logistics Agency (DLA) Troop Support Medical indefinite delivery contract. The order is for the supply of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is a firm fixed price...